Eric Lander and Leroy Hood to Address International Gathering of Brain Scientists and DNA Researchers

Apr 02, 2001, 01:00 ET from Cogent Neuroscience, Inc.

    RESEARCH TRIANGLE PARK, N.C., April 2 /PRNewswire/ -- Dr. Eric Lander,
 Director of the Whitehead Institute/MIT Center for Genome Research, and Dr.
 Leroy Hood, President and Director of the Institute for Systems Biology, will
 address separate sessions at the First Annual Symposium on Neurogenomics, a
 3-day-long gathering of international thought-leaders in the fields of
 neuroscience, genetics and drug development.
     The unprecedented conference -- which has been organized by Duke
 University's Center for Human Genetics, the Duke Medical Center's Division of
 Neurology, the University of North Carolina at Chapel Hill's Neuroscience
 Center, and Cogent Neuroscience, Inc. -- is being convened to examine the ways
 in which recent genomic discoveries are being applied toward the development
 of effective treatments for Alzheimer's Disease, Stroke, Parkinson's Disease,
 Schizophrenia and other neurological and psychiatric disorders.
     The Symposium is being held April 24-26 in Chapel Hill, North Carolina.
     Among those who will be speaking or chairing sessions there, in addition
 to Dr. Landers and Dr. Hood, are:
 
     * James D. Watson, Nobel Laureate and President of Cold Spring Harbor
       Laboratory
     * Francis Collins, Director of the National Human Genome Research
       Institute
     * Gerald Fischbach, former Director, National Institute of Neurological
       Disorders & Stroke
     * Allen Roses, Senior Vice President, Genetic Research, GlaxoSmithKline
     * Steven Hyman, Director of the National Institute of Mental Health
     * Richard Myers, Director of the Stanford Human Genome Center
 
     In addition to the scientific program, Tony Butler, Managing Director and
 Co-Head of Global Pharmaceuticals for Lehman Brothers, will chair a panel on
 optimizing interactions among allied professionals in the pharmaceutical,
 financial, legal and government arenas.
     The symposium is being sponsored by a consortium of underwriters,
 including Pfizer, IBM, Ernst & Young, Xanthon, Amersham Pharmacia Biotech, RR
 Donnelley Financial, GlaxoSmithKline, iBiomatics, Eli Lilly & Company, BIO,
 Applied Biosystems and Intersouth Partners.  The symposium's principal sponsor
 is the Nature Group, publishers of Nature, Nature Neuroscience & Nature
 Genetics.
     Registration for the symposium is available on the World Wide Web at
 http://www.neurogenomics.com or by calling (919) 688-7100 x. 5233.  For press
 materials or information on media access to the symposium, please contact the
 conference's press office at Lauren.mason@mslpr.com.
 
 

SOURCE Cogent Neuroscience, Inc.
    RESEARCH TRIANGLE PARK, N.C., April 2 /PRNewswire/ -- Dr. Eric Lander,
 Director of the Whitehead Institute/MIT Center for Genome Research, and Dr.
 Leroy Hood, President and Director of the Institute for Systems Biology, will
 address separate sessions at the First Annual Symposium on Neurogenomics, a
 3-day-long gathering of international thought-leaders in the fields of
 neuroscience, genetics and drug development.
     The unprecedented conference -- which has been organized by Duke
 University's Center for Human Genetics, the Duke Medical Center's Division of
 Neurology, the University of North Carolina at Chapel Hill's Neuroscience
 Center, and Cogent Neuroscience, Inc. -- is being convened to examine the ways
 in which recent genomic discoveries are being applied toward the development
 of effective treatments for Alzheimer's Disease, Stroke, Parkinson's Disease,
 Schizophrenia and other neurological and psychiatric disorders.
     The Symposium is being held April 24-26 in Chapel Hill, North Carolina.
     Among those who will be speaking or chairing sessions there, in addition
 to Dr. Landers and Dr. Hood, are:
 
     * James D. Watson, Nobel Laureate and President of Cold Spring Harbor
       Laboratory
     * Francis Collins, Director of the National Human Genome Research
       Institute
     * Gerald Fischbach, former Director, National Institute of Neurological
       Disorders & Stroke
     * Allen Roses, Senior Vice President, Genetic Research, GlaxoSmithKline
     * Steven Hyman, Director of the National Institute of Mental Health
     * Richard Myers, Director of the Stanford Human Genome Center
 
     In addition to the scientific program, Tony Butler, Managing Director and
 Co-Head of Global Pharmaceuticals for Lehman Brothers, will chair a panel on
 optimizing interactions among allied professionals in the pharmaceutical,
 financial, legal and government arenas.
     The symposium is being sponsored by a consortium of underwriters,
 including Pfizer, IBM, Ernst & Young, Xanthon, Amersham Pharmacia Biotech, RR
 Donnelley Financial, GlaxoSmithKline, iBiomatics, Eli Lilly & Company, BIO,
 Applied Biosystems and Intersouth Partners.  The symposium's principal sponsor
 is the Nature Group, publishers of Nature, Nature Neuroscience & Nature
 Genetics.
     Registration for the symposium is available on the World Wide Web at
 http://www.neurogenomics.com or by calling (919) 688-7100 x. 5233.  For press
 materials or information on media access to the symposium, please contact the
 conference's press office at Lauren.mason@mslpr.com.
 
 SOURCE  Cogent Neuroscience, Inc.